MPS Powered by Eureka

Current Drug Targets

ISSN: 1389-4501 (Print)
eISSN: 1873-5592 (Online)

Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes.

Current Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication full-length/mini review articles and drug clinical trial studies.

As the discovery, identification, characterization and validation of novel human drug targets for drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Special Issues With Active Call for Papers

Submission closes on: Dec 08, 2024
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics

Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at which drugs are released, enhance the bioavailability of medicines, and selectively target particular cells or tissues. Consequently, this approach enhances the therapeutic effectiveness of pharmaceutical... see more

Submission closes on: Nov 18, 2024
RNA Molecules in the Treatment of Human Diseases

Messenger and non-coding RNAs, including long and small transcripts, are mediators of gene expression. Gene expression at the RNA level shows significant aberrations in human diseases, including cancer, leukemia, lymphoma, cardiovascular diseases, and neurological disorders. Human transcripts serve either as biomarkers of diagnosis, prognosis, prediction of treatment response and/or therapy efficacy monitoring. Moreover, RNA molecules constitute important drug targets of can be used as drugs against a wide range of human diseases. This Thematic Issue... see more